Ostrowski Erik 4
4 · Akebia Therapeutics, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Ostrowski Erik
SVP, CFO, CBO & Treasurer
Transactions
- Award
Stock Option (Right to buy)
2025-01-31+292,300→ 292,300 totalExercise: $2.24Exp: 2035-01-31→ Common Stock (292,300 underlying) - Award
Common Stock
2025-01-31+194,900→ 544,900 total
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.